[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.197.185.157. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Other Articles
July 1932

STOVARSOL IN THE TREATMENT OF SYPHILIS IN INFANTS AND IN CHILDREN

Author Affiliations

CHICAGO
From the Syphilis Clinic of the Children's Memorial Hospital, Chicago.

Am J Dis Child. 1932;44(1):25-30. doi:10.1001/archpedi.1932.01950080035004
Abstract

If the oral treatment for syphilis were as efficient or more efficient than the other modes of treatment, it would have many incidental advantages. Stovarsol,1 spirocid or acetarsone—they are the same product—administered by mouth has given such superior results that we decided to test it in our clinic.

Since 1922 in animal experiments and 1924 clinically, the French have used stovarsol. Later it has been used extensively with great favor in Germany, Austria, Hungary, Czecho-Slovakia and Poland. In this country, Cregor and Gastineau2 tried it for the treatment of adults and compared its efficiency with that of neoarsphenamine.

Oral treatment offers special advantages in infants and children. Any one who has had experience in the treatment of syphilitic children knows with what difficulty and sacrifice a social worker, a bread winner, a busy mother or a caretaker brings a child to the clinic weekly over a long period.

First Page Preview View Large
First page PDF preview
First page PDF preview
×